• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.10% Nasdaq Down 0.00%

    More On SNTA

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Synta Pharmaceuticals Corp. (SNTA)

    -NasdaqCM
    0.00 0.00(0.00%) N/A
    Prev Close:N/A
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:1.00
    Beta:0.652511
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.15 - 2.23
    Volume:0
    Avg Vol (3m):781,843
    Market Cap:0.00
    P/E (ttm):N/A
    EPS (ttm):-0.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SNTA 0.00%0.00
    INFIUp 3.38%107.91M
    1 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Synta Pharmaceuticals Corp. focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. Its clinical stage drug candidate in oncology is ganetespib, an Hsp90 inhibitor, which is in Phase II clinical... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback